Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

F Disrespectful Fiduciary Responsibility

Concerned under the existential dread that "The robots could take over" and take control of the job of writer as easily as they did to that of the cashier or comedian, I attempted to create an article via an AI algoritm, the result .... There has been a lot of talk in the...

Receive 7% dividends from America's most profitable stock

Makers of cigarettes and the U.S. government must play a bizarre game... and not one American in 100,000 understands it. Everyone knows cigarettes are "evil." On Friday, the state of Kansas will ban smoking in indoor public places. And in San Francisco, they're cl...

Stocks facing revaluation: Nel, Bayer, Power Nickel with potential

Relief for Bayer. In the U.S., the company has won a victory in the dispute over compensation for illnesses caused by the chemical PCB. Is it groundbreaking and the start of a revaluation of the stock? A revaluation already seems to be underway at Power Nickel. Follo...

iBio Shares Trade Up 40% After Announcing Development of Proprietary COVID-19 Vaccine Candidates

iBio Inc. shares traded higher after the company reported that it has filed several provisional patents for its SARS-CoV-2 Virus-Like Particle platform with the U.S. Patent and Trademark Office. Biologics contract manufacturing firm iBio Inc. (IBIO:NYSE.Ame...

BioNTech, CureVac, Valeo Pharma - COVID-19 wakes up the industry

In the past, people have accepted that it usually takes about ten years to get a vaccine on the market. Careful testing with proof of success is required for a preparation to receive approvals. Since COVID-19, the pressure to develop has increased dramatically and also the pot...

Puma Biotech Shares Up More Than 20% on Q2 Earnings and Breast Cancer Drug Sales

Shares in Puma Biotechnology are trading 20% higher today after the company released Q2/19 earnings and reported positive NERLYNX revenue growth. Biopharmaceutical company Puma Biotechnology Inc. (PBYI:NADSAQ) shares opened more than 20% higher to...

SmileDirectClub Awarded US Patent for SmileShop Concept and Plans to Reopen Stores in May

SmileDirectClub shares traded 20% higher after the company reported it has been awarded a U.S. patent for its SmileShop retail concept and treatment process and that it plans to reopen stores on a rolling basis starting in May. SmileDirectClub Inc. (SDC:NASD...

Buzz on the Bullboards: 3 stocks breaking the silence of a quiet June

“Sell in May and go away” is a theme investors and stock traders know well, and during this quieter month of June ahead of summer, some public Canadian companies have been engaging in serious business. This week, we saw the TSX hit a one-month ...

Level up your trading with BMO InvestorLine’s enhanced features

With about 48 per cent of Canadians investing regularly, according to an Ipsos poll conducted in February, and more young people learning about the benefits of putting money to work than ever before, the demand for leading-edge trading platforms in terms of efficienc...

Takeover rumours: BioNTech, Cardiol Therapeutics and Novo Nordisk in focus

The biotech sector has significantly lagged behind the performance of artificial intelligence and high-tech this year. This is because of high inflation, which in turn has made an imminent interest rate cut unlikely. Nevertheless, Germany’s economic condit...
1 2 3